{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:05:08Z","timestamp":1784322308690,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.pathol.2026.04.003","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:29:39Z","timestamp":1780122579000},"page":"501-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of the 2025 Endocrine Society clinical practice guideline on the diagnosis and management of primary aldosteronism for the clinical laboratory"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2645-9588","authenticated-orcid":false,"given":"Nicola K.","family":"Sawyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Glendenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus P.","family":"Schlaich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6592-6184","authenticated-orcid":false,"given":"Damon A.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2026.04.003_bib1","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pathol.2026.04.003_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5694\/mja2.51438","article-title":"Detecting primary aldosteronism in Australian primary care: a prospective study","volume":"216","author":"Libianto","year":"2022","journal-title":"Med J Aust"},{"key":"10.1016\/j.pathol.2026.04.003_bib3","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/HJH.0000000000002441","article-title":"Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension","volume":"38","author":"Parasiliti-Caprino","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.pathol.2026.04.003_bib4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","article-title":"Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit","volume":"75","author":"Burrello","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.pathol.2026.04.003_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.pathol.2026.04.003_bib6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.pathol.2026.04.003_bib7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jbmr.3033","article-title":"Risk of fracture in primary aldosteronism: a population-based cohort study","volume":"32","author":"Wu","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.pathol.2026.04.003_bib8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamasurg.2021.0254","article-title":"Outcomes of a specialized clinic on rates of investigation and treatment of primary aldosteronism","volume":"156","author":"Liu","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.pathol.2026.04.003_bib9","first-page":"3","article-title":"Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.pathol.2026.04.003_bib10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/er.2018-00139","article-title":"The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pathol.2026.04.003_bib11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","article-title":"Primary aldosteronism - a multidimensional syndrome","volume":"18","author":"Turcu","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.pathol.2026.04.003_bib12","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an Endocrine Society clinical practice guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2026.04.003_bib13","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1210\/jc.2007-1907","article-title":"A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system","volume":"93","author":"Swiglo","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2026.04.003_bib14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.pathol.2026.04.003_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1210\/clinem\/dgac568","article-title":"Aldosterone, renin, and aldosterone-to-renin ratio variability in screening for primary aldosteronism","volume":"108","author":"Ng","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2026.04.003_bib16","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1515\/cclm-2022-1190","article-title":"Standard -20oC freezer storage protocols may cause substantial plasma renin cryoactivation","volume":"61","author":"Bonnitcha","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pathol.2026.04.003_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5694\/mja2.52062","article-title":"Aldosterone and renin concentrations and blood pressure in young Indigenous and non-Indigenous adults in the Northern Territory: a cross-sectional study","volume":"219","author":"Ng","year":"2023","journal-title":"Med J Aust"},{"key":"10.1016\/j.pathol.2026.04.003_bib18","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0025-6196(11)62105-8","article-title":"Validity of the aldosterone-renin ratio used to screen for primary aldosteronism","volume":"76","author":"Montori","year":"2001","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.pathol.2026.04.003_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1055\/a-0672-0836","article-title":"Aldosterone to renin ratio as screening tool in primary aldosteronism","volume":"127","author":"Schilbach","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.pathol.2026.04.003_bib20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/01.HYP.16.6.669","article-title":"Renal secretion and hepatic clearance of human multiple renin forms","volume":"16","author":"Abraham","year":"1990","journal-title":"Hypertension"},{"key":"10.1016\/j.pathol.2026.04.003_bib21","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1373\/clinchem.2004.033654","article-title":"Direct renin assay and plasma renin activity assay compared","volume":"50","author":"Hartman","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.pathol.2026.04.003_bib22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1055\/s-0033-1343448","article-title":"Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn's registry","volume":"45","author":"Fischer","year":"2013","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.pathol.2026.04.003_bib23","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1373\/clinchem.2006.068502","article-title":"Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps","volume":"52","author":"Schirpenbach","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.pathol.2026.04.003_bib24","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1515\/cclm-2024-1468","article-title":"Investigation of the possible cause of over-estimation of human aldosterone in plasma, using a unique, non-synthetic human aldosterone-free matrix","volume":"63","author":"Stoner","year":"2025","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pathol.2026.04.003_bib25","doi-asserted-by":"crossref","first-page":"e2027","DOI":"10.1210\/clinem\/dgab924","article-title":"The saline infusion test for primary aldosteronism: implications of immunoassay inaccuracy","volume":"107","author":"Eisenhofer","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2026.04.003_bib26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1515\/cclm-2021-1028","article-title":"Report from the HarmoSter study: impact of calibration on comparability of LC-MS\/MS measurement of circulating cortisol, 17OH-progesterone and aldosterone","volume":"60","author":"Fanelli","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pathol.2026.04.003_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.hlc.2013.08.005","article-title":"Familial hypercholesterolaemia in primary care: knowledge and practices among general practitioners in Western Australia","volume":"23","author":"Bell","year":"2014","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.pathol.2026.04.003_bib28","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.pathol.2026.04.003_bib29","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2026.04.003_bib30","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/archinte.1993.00410180075008","article-title":"The diagnosis of primary aldosteronism and separation of two major subtypes","volume":"153","author":"Weinberger","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pathol.2026.04.003_bib31","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.pathol.2026.04.003_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.16209","article-title":"Use of steroid profiling combined with machine learning for identification and subtype classification in primary aldosteronism","volume":"3","author":"Eisenhofer","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.pathol.2026.04.003_bib33","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1210\/jc.2018-01394","article-title":"Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism","volume":"103","author":"Stowasser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2026.04.003_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchromb.2007.11.005","article-title":"Determination of aldosterone in serum by liquid chromatography-tandem mass spectrometry","volume":"862","author":"Turpeinen","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.pathol.2026.04.003_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jchromb.2012.11.013","article-title":"Quantitation of aldosterone in human plasma by ultra high performance liquid chromatography tandem mass spectrometry","volume":"913\u2013914","author":"Hinchliffe","year":"2013","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.pathol.2026.04.003_bib36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jchromb.2014.08.042","article-title":"Enhancement of specificity of aldosterone measurement in human serum and plasma using 2D-LC-MS\/MS and comparison with commercial immunoassays","volume":"970","author":"Ray","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.pathol.2026.04.003_bib37","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/HJH.0000000000001735","article-title":"Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration","volume":"36","author":"Baron","year":"2018","journal-title":"J Hypertens"},{"key":"10.1016\/j.pathol.2026.04.003_bib38","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1210\/clinem\/dgz150","article-title":"Diagnosis of primary aldosteronism by seated saline suppression test-variability between immunoassay and HPLC-MS\/MS","volume":"105","author":"Thuzar","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2026.04.003_bib39","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2014-1153","article-title":"Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study","volume":"99","author":"Ahmed","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2026.04.003_bib40","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.pathol.2025.02.008","article-title":"Dual-reporting aldosterone by mass spectrometry and immunoassay in the seated saline suppression test may enhance subtype classification of patients with primary aldosteronism","volume":"57","author":"Sawyer","year":"2025","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2026.04.003_bib41","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1097\/HJH.0000000000004098","article-title":"The saline infusion test with mass spectrometric measurements of aldosterone to confirm primary aldosteronism","volume":"43","author":"Pamporaki","year":"2025","journal-title":"J Hypertens"},{"key":"10.1016\/j.pathol.2026.04.003_bib42","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1161\/HYPERTENSIONAHA.124.23029","article-title":"Steroidomics-based screening for primary aldosteronism: impact of antihypertensive drugs","volume":"81","author":"Constantinescu","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.pathol.2026.04.003_bib43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2026.04.003_bib44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/ajh\/hpaf163","article-title":"Is it time to retire confirmatory testing for primary aldosteronism?","volume":"39","author":"Kline","year":"2026","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pathol.2026.04.003_bib45","doi-asserted-by":"crossref","first-page":"948","DOI":"10.7326\/ANNALS-24-03153","article-title":"Confirmatory testing for primary aldosteronism: a study of diagnostic test accuracy","volume":"178","author":"Leung","year":"2025","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pathol.2026.04.003_bib46","doi-asserted-by":"crossref","first-page":"L36","DOI":"10.1093\/ejendo\/lvaf232","article-title":"The not-so-shortcomings of seated saline suppression testing in primary aldosteronism","volume":"193","author":"Stowasser","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pathol.2026.04.003_bib47","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.125.26008","article-title":"Seated saline suppression test for lateralizing primary aldosteronism","volume":"83","author":"Leung","year":"2026","journal-title":"Hypertension"},{"key":"10.1016\/j.pathol.2026.04.003_bib48","doi-asserted-by":"crossref","first-page":"948","DOI":"10.7326\/ANNALS-24-03153","article-title":"Confirmatory testing for primary aldosteronism: a study of diagnostic test accuracy","volume":"178","author":"Leung","year":"2025","journal-title":"Ann Int Med"},{"key":"10.1016\/j.pathol.2026.04.003_bib49","doi-asserted-by":"crossref","first-page":"948","DOI":"10.7326\/ANNALS-24-03153","article-title":"Confirmatory testing for primary aldosteronism: a study of diagnostic test accuracy","volume":"178","author":"Leung","year":"2025","journal-title":"Ann Int Med"},{"key":"10.1016\/j.pathol.2026.04.003_bib50","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/HYPERTENSIONAHA.123.21910","article-title":"Multifocal, asymmetric bilateral primary aldosteronism cannot be excluded by strong adrenal vein sampling lateralization: an international retrospective cohort study","volume":"81","author":"Turcu","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.pathol.2026.04.003_bib51","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/ejendo\/lvaf170","article-title":"Discordance and shortcomings of aldosterone suppression tests in primary aldosteronism","volume":"193","author":"Tsai","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pathol.2026.04.003_bib52","doi-asserted-by":"crossref","first-page":"L25","DOI":"10.1093\/ejendo\/lvaf219","article-title":"Discordance and shortcomings of aldosterone suppression tests in primary aldosteronism","volume":"193","author":"Marzano","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pathol.2026.04.003_bib53","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/HJH.0000000000000880","article-title":"Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism","volume":"34","author":"Burrello","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.pathol.2026.04.003_bib54","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","article-title":"Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021","volume":"69","author":"Naruse","year":"2022","journal-title":"Endocr J"},{"key":"10.1016\/j.pathol.2026.04.003_bib55","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/HYPERTENSIONAHA.123.22281","article-title":"Unilateral primary aldosteronism: long-term disease recurrence after adrenalectomy","volume":"81","author":"Tetti","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.pathol.2026.04.003_bib56","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/HYPERTENSIONAHA.113.01601","article-title":"Plasma metanephrine for assessing the selectivity of adrenal venous sampling","volume":"62","author":"Dekkers","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.pathol.2026.04.003_bib57","article-title":"The value of plasma metanephrine measurements during adrenal vein sampling","volume":"13","author":"Carroll","year":"2024","journal-title":"Endocr Connect"},{"key":"10.1016\/j.pathol.2026.04.003_bib58","doi-asserted-by":"crossref","first-page":"e720","DOI":"10.1210\/clinem\/dgad179","article-title":"Prevalence of cortisol cosecretion in patients with primary aldosteronism: role of metanephrine in adrenal vein sampling","volume":"108","author":"Buffolo","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2026.04.003_bib59","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1161\/HYPERTENSIONAHA.124.23418","article-title":"Circulating miRNAs and machine learning for lateralizing primary aldosteronism","volume":"81","author":"V\u00e9kony","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.pathol.2026.04.003_bib60","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jc.2015-3431","article-title":"A novel CYP11B2-specific imaging agent for detection of unilateral subtypes of primary aldosteronism","volume":"101","author":"Abe","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pathol.2026.04.003_bib61","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1056\/NEJMc2507481","article-title":"Adrenal aldosterone synthase expression imaging in primary aldosteronism","volume":"393","author":"\u00c5rstad","year":"2025","journal-title":"N Engl J Med"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302526005295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302526005295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T20:33:56Z","timestamp":1784320436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302526005295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0031302526005295"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2026.04.003","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the 2025 Endocrine Society clinical practice guideline on the diagnosis and management of primary aldosteronism for the clinical laboratory","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2026.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}